BioAmber Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2017. For the quarter, product sales were $2,123,000 against $1,458,000 a year ago. Operating loss was $10,627,000 against $8,508,000 a year ago. Loss before income taxes was $1,366,000 against $12,530,000 a year ago. Net loss was $1,378,000 against $12,536,000 a year ago. Net income attributable to BioAmber Inc. shareholders was $106,000 against loss of $10,946,000 a year ago. Net income per share attributable to BioAmber Inc. shareholders – basic was $0.003 against loss of $0.39 a year ago. Net cash used in operating activities was $10,612,000 against $20,284,000 a year ago. Acquisition of property and equipment and intangible asset, net of disposals was $255,000 against $26,000 a year ago. Adjusted net loss attributable to BioAmber Inc. shareholders was $10,464,000 against $8,112,000 a year ago. Adjusted net loss per share attributable to BioAmber Inc. shareholders – basic was $0.31 against $0.29 a year ago.